Home › Funds › Cormorant Asset Management, LP › OLMA

Cormorant Asset Management, LP position in OLMA

OLEMA PHARMACEUTICALS INC · Health Care

Cormorant Asset Management, LP reported holding 2,150,000 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$26.9M, representing 1.38% of its reported portfolio and ranking #22 among its reported holdings. Cormorant Asset Management, LP has disclosed OLMA holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.15M sh
Reported value held$26.90M
Portfolio Weight1.38%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's OLMA position evolved

Cormorant Asset Management, LP first disclosed a stake in OLMA in Q3 2023 at 4,504,764 shares (US$55.6M). The position peaked in Q4 2025 at 2,750,000 shares, worth US$68.8M. Across 5 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,150,000 shares valued at US$26.9M — an increase of 1,650,000 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2023 (shares fell 19% over the following quarter), a 82% trim in Q1 2026 (shares fell 16% over the following quarter), a 330% increase in Q2 2026 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.50M $55.63M New
Q4 2023 2.46M $34.47M Reduce
Q4 2025 2.75M $68.75M New
Q1 2026 500.00K $7.46M Reduce
Q2 2026 2.15M $26.90M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OLMA and 13F data

OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OLMA

All OLMA fund holders →

FAQ

How long has Cormorant Asset Management, LP held OLMA?

Cormorant Asset Management, LP has disclosed OLMA holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

What is Cormorant Asset Management, LP's current position in OLMA?

As of Q2 2026, Cormorant Asset Management, LP holds 2.15M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $26.90M, representing 1.38% of its reported portfolio and ranking #22.

Has Cormorant Asset Management, LP been buying or selling OLMA?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP increased its position in OLMA. The position peaked in Q4 2025 at 2.75M shares.

Which other funds hold OLMA?

Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.